Article Text

Download PDFPDF
Unexpected myopathy associated with a mutation in MYBPC3 and misplacement of the cardiac myosin binding protein C
  1. Homa Tajsharghi1,
  2. Trond P Leren2,
  3. Saba Abdul-Hussein1,
  4. Mar Tulinius3,
  5. Leif Brunvand4,
  6. Hilde M Dahl4,
  7. Anders Oldfors1
  1. 1Department of Pathology, Institute of Biomedicine, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden
  2. 2Medical Genetics Laboratory, Department of Medical Genetics, Oslo University Hospital, Rikshospitalet, Oslo, Norway
  3. 3Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden
  4. 4Department of Pediatrics, Ullevål University Hospital, Oslo, Norway
  1. Correspondence to Professor Anders Oldfors, Department of Pathology, Sahlgrenska University Hospital, SE-413 45 Gothenburg, Sweden; anders.oldfors{at}


Background Myosin binding protein C (MyBPC) is essential for the structure of the sarcomeres in striated muscle. There is one cardiac specific isoform and two skeletal muscle specific isoforms. Mutations in MYBPC3 encoding the cardiac isoform cause cardiomyopathy.

Methods and results We have identified an infant with fatal cardiomyopathy due to a homozygous mutation, p.R943X, in MYBPC3. The patient also had an unexpected skeletal myopathy. The patient expressed the cardiac specific MyBPC isoform in skeletal muscle at transcript and protein levels. Numerous muscle fibres expressing the mutant cardiac isoform showed structural abnormalities with disorganisation of sarcomeres and depletion of myosin thick filaments.

Conclusions The surprising identification of a skeletal myopathy in this patient was due to aberrant expression of mutant cardiac MyBPC in skeletal muscle.

  • Cardiomyopathy
  • genetics
  • muscle disease
  • neuromuscular disease

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Funding The study was supported by the Swedish Research Council (Medicine; proj No 07122).

  • Competing interests None.

  • Ethics approval This study was conducted with the approval of the Regional Ethical Committee of Western Sweden.

  • Provenance and peer review Not commissioned; externally peer reviewed.